WHWKWhitehawk Therapeutics Inc. Common Stock

4.730USD-2.87%Mkt Cap: 269.65M $P/E:

Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides three next generation antibody drug conjugates (ADC) p…